This inventor holds 1 USPTO granted patent. Top assignee: Nanohybrid Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Yong-Joo Jun: Innovator in Anticancer Agents
Introduction
Yong-Joo Jun is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapeutic agents. His work focuses on creating targeted and effective solutions for combating cancer.
Latest Patents
Yong-Joo Jun holds a patent for a "Tumor selective and biodegradable cyclotriphosphazene-platinum(II) conjugate anticancer agent, and preparation method thereof." This patent discloses a novel cyclotriphosphazene-platinum(II) complex conjugate anticancer agent that demonstrates high selectivity to tumor tissues. The agent utilizes the enhanced permeability and retention effect in tumor tissues, making it a promising candidate for effective cancer treatment.
Career Highlights
Yong-Joo Jun is associated with Nanohybrid Co., Ltd., where he continues to advance his research in the field of oncology. His work has garnered attention for its potential to improve cancer therapies and patient outcomes.
Collaborations
He collaborates with notable colleagues, including Youn-Soo Sohn and Ji-Young Yu, who contribute to his research efforts and innovations in anticancer agents.
Conclusion
Yong-Joo Jun's contributions to the development of targeted anticancer agents highlight his role as an influential inventor in the medical field. His innovative approaches promise to enhance cancer treatment and improve the quality of life for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile